Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Summary

The purpose of this study is to determine if naloxegol can be used in the treatment of opioid-induced constipation in patients with cancer and pain. This phase 4 study consists of a two week randomized double blind period followed by a two week open-label period.

Timeline

Start

2016-09

Primary completion

2018-01-11

Completion

2018-01-11

Outcome

Outcome not reported

Stopped (Enrollment): “The study was stopped due to challenges recruiting eligible patients.”

Drugs

Indications